Latest news with #preventivehealthcare
Associated Press
a day ago
- Health
- Associated Press
JBA AI Earns FDA SaMD Recognition
A New Era of Accessible Health Monitoring GARDEN GROVE, CALIFORNIA / ACCESS Newswire / June 9, 2025 / JBA AI, the flagship health-tech division under AQ Pharmaceuticals, Inc. and JBA Brands, proudly announces several major global milestones in its mission to make preventive healthcare more accessible, intelligent, and AI Infographic JBA AI has been officially recognized by the United States Food and Drug Administration (FDA) as a Software as a Medical Device (SaMD). In addition, the platform has now received Class B Medical Device approval from Vietnam's Ministry of Health. These achievements affirm the platform's safety, clinical effectiveness, and international credibility. The JBA AI mobile application is already available globally for Android users and will soon be released on iOS. It enables contactless, non-invasive vital signs monitoring directly through smartphones or tablets. In just 60 seconds, the app delivers insights on over nine key health metrics. These include heart rate, heart rate variability, blood oxygen saturation, respiratory rate, stress index, and estimated glucose and blood pressure trends. This is achieved using AI-powered facial signal analysis through camera-based remote photoplethysmography technology. Expanding its impact even further, JBA AI has partnered with one of Vietnam's largest financial institutions, which serves more than 30 millions members. Together, they are preparing to launch JBA AI nationwide, making preventive health monitoring more accessible through a trusted and widespread digital network. 'JBA AI is more than a health app - it's a certified medical device. Recognized by both the FDA and Vietnam's Ministry of Health,' said Tracy Trang Nguyen, founder and CEO of JBA AI. 'We're proud to deliver trusted, clinically guided tools for daily health monitoring worldwide.' Nguyen is a Vietnamese American engineer and wellness industry leader who developed JBA AI after surviving cancer. Her personal health journey inspired her to combine advanced artificial intelligence with affordable wellness solutions. Under her leadership, JBA AI complements other products within the JBA Brands portfolio, such as GlucoTrojan, Joint Revive Fucoidan, and Vegan Collagen, to form a fully integrated health ecosystem. JBA AI is already gaining traction and is starting to expand into pharmacies, corporate wellness programs, public health campaigns, and family clinics across the United States, Vietnam, and other countries. The platform's franchise-ready model supports rapid local deployment while keeping costs low and impact high. It is designed to help people monitor their health in real-time, without the need for needles, wearable devices or clinic visits. JBA AI is currently welcoming franchisees, affiliates, and institutional partners to help bring this technology to communities around the world. Whether at home or in partnership with healthcare providers, JBA AI is redefining preventive care through data-driven technology and a compassionate approach to well-being. Contact Information Catherine Marino Marketing Manager [email protected] (+1) 714 903 1009 SOURCE: AQP One, Inc. press release
Globe and Mail
20-05-2025
- Business
- Globe and Mail
Nutraceutical Excipients Market Size, Emerging Trends, Growth Drivers, Key Segments, and Forecasts
"MarketsandMarkets™" Nutraceutical Excipients Market by Product Source (Organic Chemicals, Inorganic Chemicals), Functionality (Binders, Colorants, Flavors & Sweeteners), End Product, Formulation, Functionality Application and Region The global nutraceutical excipients market is projected to grow from USD 4.2 billion in 2023 to USD 6.1 billion by 2028, registering a compound annual growth rate (CAGR) of 7.7% during the forecast period. This growth is driven by a heightened focus on preventive healthcare and the increasing consumption of dietary supplements. As consumer demand rises, advancements in processing technologies—such as spray drying, freeze-drying, and granulation—are enhancing the functionality of excipients by improving flowability, compressibility, and formulation consistency. What Are Nutraceutical Excipients? Nutraceutical excipients are inactive substances used alongside active ingredients in nutraceutical formulations. Their roles are vital — from improving stability and enhancing bioavailability to ensuring proper taste, color, and texture. These substances don't provide direct health benefits themselves, but without them, delivering effective, consumer-friendly products would be nearly impossible. Common nutraceutical excipients include: Binders and fillers (e.g., microcrystalline cellulose) Disintegrants (e.g., starch) Flavoring agents and sweeteners (e.g., stevia, sucralose) Coating agents (e.g., hydroxypropyl methylcellulose) Preservatives and stabilizers Nutraceutical Excipients Market Trends Rising Demand for Functional Foods & Supplements: Health-conscious consumers are increasingly turning to dietary supplements for immunity, gut health, cognitive support, and more—boosting demand for well-formulated nutraceuticals. Innovation in Delivery Systems: The push toward chewables, gummies, effervescent tablets, and liquid capsules has created a need for innovative excipients that support alternative formats. Clean Label Movement: Manufacturers are seeking natural, non-GMO, allergen-free excipients to meet clean label standards and consumer expectations for transparency. Aging Global Population: As the global population ages, especially in developed economies, demand for nutraceuticals for joint health, brain health, and cardiovascular support continues to grow—driving the need for better, more bioavailable formulations. Taste Masking Excipients: Enhancing Consumer Acceptance Taste masking excipients play a vital role in improving the palatability of nutraceutical products, which often contain active ingredients with unpleasant flavors or odors. These excipients are especially important for products aimed at children and the elderly, who are typically more sensitive to taste. By enhancing flavor profiles and overall sensory appeal, taste-masking agents contribute to better adherence to supplement regimens and consistent consumption. As demand for functional foods and supplements becomes more integrated into daily wellness routines, manufacturers increasingly rely on these excipients to differentiate their products and boost consumer satisfaction in a competitive marketplace. Download PDF Brochure: Fillers & Diluents: Supporting Formulation Consistency The fillers and diluents segment is projected to hold the second-largest share of the nutraceutical excipients market by functionality. These excipients are essential for adding bulk to formulations, ensuring uniform tablet or capsule size, and supporting consistent nutrient dosage. In addition to enhancing flow properties and reducing powder segregation, certain fillers and diluents aid in tablet disintegration and dissolution, promoting optimal nutrient absorption. Their role in streamlining manufacturing and improving product quality underscores their growing importance within the market. North America dominates the Nutraceutical Excipients Market Share. North America is expected to maintain its position as the leading region in the nutraceutical excipients market throughout the forecast period. This dominance stems from the region's mature nutraceutical and pharmaceutical sectors, which serve as fertile ground for excipient innovation. Significant investment in R&D fosters the development of advanced excipients with enhanced bioavailability and targeted delivery systems. Moreover, North America benefits from a well-established retail ecosystem—including e-commerce, specialty health stores, and mainstream supermarkets—that ensures broad accessibility to nutraceutical products. These factors collectively contribute to the region's strong market presence and ongoing expansion. Leading Nutraceutical Excipients Companies: The key players in the nutraceutical excipients market include International Flavors & Fragrances Inc. (US), Kerry Group plc (Ireland), Ingredion (US), Sensient Technologies Corporation (US), Associated British Foods plc (UK), BASF SE (Germany), Roquette Frères (France), MEGGLE GmbH & Co. KG (Germany), Cargill, Incorporated (US), Ashland (US), IMCD (Netherlands), Hilmar Cheese Company, Inc. (US), Air Liquide (France), Azelis Group (Luxembourg), and Biogrund GmbH (Germany). About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
Globe and Mail
16-05-2025
- Health
- Globe and Mail
The Wellness Thonglor Celebrates Over a Decade of Preventive Healthcare Leadership in Bangkok
Bangkok, Thailand - As one of Bangkok's most established wellness centers, The Wellness Thonglor proudly celebrates more than 10 years of delivering premium preventive healthcare services. Located in the heart of the vibrant Thonglor district, they have become a trusted destination for individuals seeking long-term vitality, disease prevention, and natural healing — all under one roof. In a time when global attention is shifting toward proactive health and wellness, The Wellness Thonglor continues to lead the way with its evidence-based approach and integrative philosophy. The wellness center merges cutting-edge medical technologies with personalized treatment plans, offering a comprehensive alternative to reactive healthcare models. 'Our goal has always been to help people feel their best before illness arises, Whether it's boosting energy, improving immunity, or addressing the root cause of fatigue and imbalance, we provide a space where proactive health is not just encouraged — it's achievable.' - said Khun Kochavee Bavornwattanakorn, Founder of The Wellness Thonglor. The center offers a wide array of services, including vitamin IV drip therapy, detox programs, advanced health screenings, anti-aging and hormonal balance treatments, physical therapy, and integrative medicine. Clients can also benefit from natural and alternative treatments such as NK cell therapy, Bach Flower remedies, and custom wellness consultations — all designed to support the body's ability to heal and maintain balance. In recent years, Thailand has emerged as a global wellness destination, drawing international visitors not only for its hospitality and culture but also for its trusted healthcare options. The Wellness Thonglor is proud to be part of this movement, catering to both locals and expatriates with services that are rooted in science, tailored to the individual, and delivered with the warmth Thailand is known for. Whether you're managing chronic fatigue, seeking preventive support, or simply striving to feel healthier every day, they provide a holistic sanctuary that empowers you to take charge of your health — naturally and effectively. About The Wellness Thonglor Established over a decade ago, The Wellness Thonglor is a leading integrative medical center in Bangkok, Thailand, specializing in preventive healthcare and holistic wellness. With a focus on proactive, personalized care, the center offers services ranging from vitamin therapy and detox to hormonal balancing, rehabilitation, and integrative treatments. The center is dedicated to helping individuals achieve optimal well-being through science-based methods and compassionate care.
Yahoo
14-05-2025
- Business
- Yahoo
Cytogenetics Market Research 2025 Featuring Thermo Fisher Scientific, Abbott Laboratories, Agilent, Revvity, Bio-Rad, Applied Spectral Imaging, Quest, F. Hoffmann-La Roche, Danaher, Illumina, Sysmex
The Cytogenetics Market, valued at $2.6 billion in 2023, is projected to reach $5.5 billion by 2031, growing at a CAGR of 9.6% from 2024-2031. Key growth drivers include a focus on preventive healthcare, rising genetic abnormalities, and an aging population. However, awareness, reimbursement issues, and technical complexities may hinder growth. Opportunities in emerging economies and predictive genetic testing are identified. The Asia-Pacific market is expected to register the highest CAGR due to R&D spending and an increase in diagnostic labs. Leading market players include Thermo Fisher Scientific, Abbott Laboratories, and Illumina. Dublin, May 14, 2025 (GLOBE NEWSWIRE) -- The "Cytogenetics Market Size, Share, Forecast, & Trends Analysis by Offering (Consumables, Instruments, Software, Services), Technique (Comparative Genomic Hybridization, FISH, Karyotyping), Application (Clinical, Research), End User - Forecast to 2031" has been added to offering. The Cytogenetics Market, valued at $2.6 billion in 2023, is poised to grow to $5.5 billion by 2031, with a CAGR of 9.6% from an estimated $2.9 billion in 2024. This robust growth can be attributed to the increasing emphasis on preventive healthcare, rising prevalence of genetic abnormalities, an aging population, and an increase in chronic diseases. The need to curb rising healthcare costs and a focus on research and clinical diagnostics further propel this market. However, challenges such as lack of awareness about emerging diagnostic technologies, unfavorable reimbursement scenarios, and the complexity of equipment may hinder growth. Opportunities abound in emerging economies such as China, India, South Korea, and Southeast Asia, where there is a growing focus on target-based therapies and genetic testing. However, concerns over genetic data security, scaling genomic technologies, and lack of standardized approaches present notable challenges. The market's competitive landscape has been shaped by major players like Thermo Fisher Scientific, Abbott Laboratories, Agilent Technologies, Revvity, Bio-Rad Laboratories, Applied Spectral Imaging, Quest Diagnostics, F. Hoffmann-La Roche, Danaher Corporation, Illumina, and Sysmex Corporation. Strategic initiatives by these companies have been pivotal in shaping industry trends. The consumables segment is expected to register the highest CAGR of 10.2% through the forecast period, driven by heightened demand for routine cytogenetic testing and technological advances. The comparative genomic hybridization technique accounted for the largest share of 56.7% in 2024, thanks to technological improvements and its role in early disease diagnosis. In terms of application, clinical applications dominated with a share of 82.6% in 2024, bolstered by increased prevalence of genetic disorders and cancers, advancements in diagnostic technology, patient awareness initiatives, and personalized medicine adoption. Geographically, Asia-Pacific is anticipated to lead with a 10.2% CAGR, fueled by increased pharmaceutical R&D spend, growth in the biotech industry, and a rise in diagnostic laboratories. The overall geographical analysis covers North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, providing insights into regional dynamics. Scope of the Report: Cytogenetics Market Assessment - by Offering: Consumables Kits & Reagents Testing Kits Probes Other Reagents and Consumables Instruments Software Services Cytogenetics Market Assessment - by Technique: Comparative Genomic Hybridization Fluorescence In Situ Hybridization (FISH) Karyotyping Other Techniques Cytogenetics Market Assessment - by Application: Clinical Applications Prenatal & Genetic Testing Oncology Other Clinical Applications Research Applications Cytogenetics Market Assessment - by End User: Clinical & Diagnostic Laboratories Pharmaceutical & Biotechnology Companies Research & Academic Institutes Other End Users Cytogenetics Market Assessment - by Geography: North America Europe Asia-Pacific Latin America Middle East & Africa Companies Featured Thermo Fisher Scientific Inc. (U.S.) Abbott Laboratories (U.S.) Agilent Technologies Inc. (U.S.) Revvity Inc. (U.S.) Bio-Rad Laboratories Inc. (U.S.) Applied Spectral Imaging Inc. (U.S.) Quest Diagnostics Incorporated (U.S.) F. Hoffmann-La Roche Ltd. (Switzerland) Danaher Corporation (U.S.) Illumina Inc. (U.S.) Sysmex Corporation (Japan) For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
